BioReliance, Sigma-Aldrich deal

Sigma-Aldrich completed its acquisition of CRO BioReliance from private equity firm Avista Capital Partners for $350 million in cash. BioReliance will become part of Sigma-Aldrich's SAFC custom manufa...